United States · 
Who invested in LEXEO Therapeutics?
LEXEO Therapeutics's investors include RA Capital Management, Novo Holdings, Janus Henderson Investors, Invus and Adage Capital Management.
United States · Funded startup
Who invested in LEXEO Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow LEXEO Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$154Mraised across 1 round since 2025, from 1 source
- Latest round
- Round, $154MOct 2025
- Investors
- 5
The rounds
- Oct 2025Round$154M
Source recorded
Founders and team
From LEXEO Therapeutics's own website: 8 on the team.
Everyone who backed them
Adage Capital ManagementAsset manager1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about LEXEO Therapeutics
How much has LEXEO Therapeutics raised?
LEXEO Therapeutics has raised $154M across 1 round since 2025.
When did LEXEO Therapeutics last raise?
LEXEO Therapeutics's most recent round was an Undisclosed round of $154M in Oct 2025.
What was LEXEO Therapeutics's biggest round?
Its most recent round, $154M in Oct 2025, is also its largest on record.
Who backed LEXEO Therapeutics first?
LEXEO Therapeutics's first round on record, in Oct 2025, was backed by RA Capital Management, Novo Holdings and Janus Henderson Investors and 2 others.
What stage is LEXEO Therapeutics at?
LEXEO Therapeutics's latest named round is an Undisclosed round, in Oct 2025.
Where is LEXEO Therapeutics based?
LEXEO Therapeutics is based in the United States.
Companies like LEXEO Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.